Catalent
CTLT
#1770
Rank
โ‚น1.071 T
Marketcap
โ‚น5,902
Share price
0.00%
Change (1 day)
21.72%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -โ‚น527.16

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น588.56. In 2023 the company made an earnings per share (EPS) of -โ‚น632.26 a decrease over its 2022 EPS that were of โ‚น211.06.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น527.16-16.62%
2023-โ‚น632.26-399.56%
2022โ‚น211.06-30.58%
2021โ‚น304.0479.67%
2020โ‚น169.22114.12%
2019โ‚น79.03-15%
2018โ‚น92.9875.44%
2017โ‚น53.00-22.97%
2016โ‚น68.80-59.56%
2015โ‚น170.15282.05%
2014โ‚น44.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-โ‚น30.68-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
-โ‚น554.15-5.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-โ‚น69.73-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
-โ‚น137.61-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA